InMed Pharmaceuticals (INM) EBITDA (2021 - 2026)
InMed Pharmaceuticals (INM) posted quarterly EBITDA of -$2.4 million for Q1 2026, down 23.64% year-over-year from -$3.1 million in Q1 2025, and down 12.19% quarter-over-quarter from -$2.1 million in Q4 2025.
InMed Pharmaceuticals (INM) EBITDA (2021 - 2026) Analysis & Trends
InMed Pharmaceuticals' EBITDA history runs 6 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- In Q1 2026, EBITDA fell 23.64% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$8.8 million (down 10.33% YoY), while the FY2025 annual figure was -$7.9 million, up 3.05% from the prior year.
- EBITDA for Q1 2026 stood at -$2.4 million, down from -$2.1 million in the prior quarter.
- The five-year high for EBITDA was -$485150.0 in Q2 2023, with the low at -$6.5 million in Q2 2022.
- The 5-year median for EBITDA is -$2.2 million (2023), against an average of -$2.4 million.
- The sharpest annual moves came in 2023 and 2024: EBITDA surged 92.56% in 2023, then sank 319.3% in 2024.
- InMed Pharmaceuticals' EBITDA stood at -$2.2 million in 2022, then increased by 25.7% to -$1.6 million in 2023, then slumped by 37.03% to -$2.3 million in 2024, then grew by 6.72% to -$2.1 million in 2025, then dropped by 12.19% to -$2.4 million in 2026.
- Business Quant data shows INM's EBITDA at -$2.4 million in Q1 2026, -$2.1 million in Q4 2025, and -$1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.56 Mn | 1.32 Mn | - | -2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.36 Mn |
| Dec 31, 2025 | -2.10 Mn |
| Sep 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -2.47 Mn |
| Mar 31, 2025 | -1.91 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Mar 31, 2024 | -1.84 Mn |
| Dec 31, 2023 | -1.64 Mn |
| Sep 30, 2023 | -2.67 Mn |
| Jun 30, 2023 | -485,150.00 |
| Mar 31, 2023 | -2.15 Mn |
| Dec 31, 2022 | -2.21 Mn |
| Sep 30, 2022 | -3.58 Mn |
| Jun 30, 2022 | -6.52 Mn |
| Mar 31, 2022 | -3.54 Mn |
| Dec 31, 2021 | -4.31 Mn |
| Sep 30, 2021 | -2.97 Mn |